Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term “metal ions in bacterial cell wall” refers to the widespread ability of bacterial cell wall components—primarily peptidoglycan, teichoic acids (in Gram-positive bacteria), and lipopolysaccharides (in Gram-negative bacteria)—to bind divalent and other metal ions (such as Mg²⁺, Ca²⁺, Fe²⁺/Fe³⁺, Zn²⁺, Mn²⁺) via anionic phosphate/carboxyl groups or coordinated interactions. - These binding interactions are critical for maintaining **cell wall structure**, **ionic homeostasis**, and **enzyme function**. - Metal binding provides sites for essential ions, helps stabilize the wall’s architecture, regulates permeability, and contributes to resistance or sensitivity to antimicrobial strategies targeting the cell envelope. - While disruption of metal homeostasis in the cell wall is a promising antimicrobial approach, the lack of specificity and the distributed, non-protein nature of these binding sites complicate classic “targeted” drug discovery. Summary: “Metal ions in bacterial cell wall” is not a discrete, therapeutically targetable molecule, but rather refers to a set of distributed physicochemical binding sites crucial for bacterial viability. Research exploits these interactions for antibacterial strategies, but this entity should not be considered a conventional drug target such as a specific receptor or enzyme.
Metal chelation: agents bind and sequester wall-bound metals, destabilizing structure Membrane/cell wall disruption: metal ions or chelators may increase permeability and oxidative stress Ionophores: alter ion gradients across the membrane via interaction with bound/active metals
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metal ion binding sites in bacterial cell wall (None standardized. If required, "MIBS-BCW" (Metal Ion Binding Sites—Bacterial Cell Wall) is a possible descriptive abbreviation, but there is no established term.).